Pegylated liposomal doxorubicin (Duomeisu®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study

被引：0
|
作者：
Hanfang Jiang
Huiping Li
Guohong Song
Lijun Di
Bin Shao
Ying Yan
Xiaoran Liu
Yifei Chen
Ruyan Zhang
Ran Ran
Yaxin Liu
Xinyu Gui
Nan Wang
Huan Wang
机构：
[1] Peking University Cancer Hospital & Institute,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology
来源：
Breast Cancer Research and Treatment | 2023年 / 199卷
关键词：
Pegylated liposomal doxorubicin; Metastatic breast cancer; HER2-negative; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：67 / 79
页数：12
相关论文
共 50 条
  • [21] Sequential neoadjuvant chemotherapy using pegylated liposomal doxorubicin and cyclophosphamide followed by taxanes with complete trastuzumab and pertuzumab treatment for HER2-positive breast cancer: A phase Ⅱ single-arm study
    Yaping Yang
    Liang Jin
    Yudong Li
    Nanyan Rao
    Chang Gong
    Shunrong Li
    Jiannan Wu
    Jinghua Zhao
    Linxiaoxiao Ding
    Fengxia Gan
    Jun Zhang
    Ruifa Feng
    Zhenzhen Liu
    Qiang Liu
    Chinese Journal of Cancer Research, 2024, 36 (01) : 55 - 67
  • [22] The Efficacy of Eribulin Monotherapy after Anthracycline and Taxane in HER2-Negative Metastatic Breast Cancer
    Tsushita, Natsuko
    Shimoi, Tatsunori
    Kitano, Atsuko
    Shimomura, Akihiko
    Kodaira, Makoto
    Yunokawa, Mayu
    Yonemori, Kan
    Shimizu, Chikako
    Fujiwara, Yasuhiro
    Tamura, Kenji
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
    Zhu, Anjie
    Yuan, Peng
    Hu, Nanlin
    Li, Mingzhou
    Wang, Wenmiao
    Wang, Xue
    Yue, Jian
    Wang, Jiayu
    Luo, Yang
    Ma, Fei
    Zhang, Pin
    Li, Qing
    Xu, Binghe
    Cao, Shanbo
    Lippi, Giuseppe
    Naito, Yoichi
    Osman, Mohammed A.
    Marta, Gustavo N.
    Franceschini, Gianluca
    Orlandi, Armando
    CANCER BIOLOGY & MEDICINE, 2021, 18 (03) : 875 - +
  • [24] Phase II Study of Bortezomib and Pegylated Liposomal Doxorubicin in the Treatment of Metastatic Breast Cancer
    Irvin, William J., Jr.
    Orlowski, Robert Z.
    Chiu, Wing-Keung
    Carey, Lisa A.
    Collichio, Frances A.
    Bernard, Philip S.
    Stijleman, Inge J.
    Perou, Charles
    Ivanova, Anastasia
    Dees, E. Claire
    CLINICAL BREAST CANCER, 2010, 10 (06) : 465 - 470
  • [25] Phase II study of apatinib plus vinorelbine, a novel combination of all-oral regimen in heavily pretreated patients with metastatic HER2-negative breast cancer
    Zhu, Anjie
    Yuan, Peng
    Wang, Jiayu
    Ma, Fei
    Luo, Yang
    Fan, Ying
    Li, Qing
    Zhang, Pin
    Xu, Binghe
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] Pyrotinib combined with metronomic oral etoposide (VP-16) in heavily pretreated HER2-positive metastatic breast cancer: A single-arm, phase II study
    Liu, J.
    He, M.
    Jiang, M.
    Zhou, S.
    Zhang, M.
    Li, Y.
    Chen, S.
    Cai, R.
    Mo, H.
    Lan, B.
    Ma, F.
    Xu, B.
    Li, Q.
    ANNALS OF ONCOLOGY, 2024, 35 : S379 - S379
  • [27] Nab-paclitaxel plus bevacizumab in heavily pretreated HER2-negative metastatic breast cancer
    Miano, S. T.
    Rossi, G.
    Marsili, S.
    Petrioli, R.
    Pascucci, A.
    Francini, G.
    ANNALS OF ONCOLOGY, 2015, 26 : 22 - 23
  • [28] Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial
    Lopez-Miranda, Elena
    Perez-Garcia, Jose Manuel
    Di Cosimo, Serena
    Brain, Etienne
    Ravnik, Maja
    Escriva-de-Romani, Santiago
    Vidal, Maria
    Gligorov, Joseph
    Borstnar, Simona
    Calabuig, Laura
    Sampayo-Cordero, Miguel
    Malfettone, Andrea
    Llombart-Cussac, Antonio
    Suter, Thomas M.
    Cortes, Javier
    CANCERS, 2020, 12 (12) : 1 - 14
  • [29] Phase II study of pseudomonas aeruginosa-mannose-sensitive hemagglutinin in combination with capecitabine for HER2-negative metastatic breast cancer pretreated with anthracycline and taxane
    Lv, Fangfang
    Cao, Jun
    Liu, Zhebin
    Wang, Zhong Hua
    Zhang, Jian
    Zhang, Sheng
    Wang, Leiping
    Zhao, Xinmin
    Shao Zhimin
    Wang, Biyun
    Hu, Xi-Chun
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] A phase II, multicenter, single-arm trial of eribulin as first-line chemotherapy for HER2-negative locally advanced or metastatic breast cancer
    Takashima, Tsutomu
    Tokunaga, Shinya
    Tei, Seika
    Nishimura, Shigehiko
    Kawajiri, Hidemi
    Kashiwagi, Shinichiro
    Yamagata, Shigehito
    Noda, Satoru
    Nishimori, Takeo
    Mizuyama, Yoko
    Sunami, Takeshi
    Tezuka, Kenji
    Ikeda, Katsumi
    Ogawa, Yoshinari
    Onoda, Naoyoshi
    Ishikawa, Tetsuro
    Kudoh, Shinzoh
    Takada, Minoru
    Hirakawa, Kosei
    SPRINGERPLUS, 2016, 5 : 1 - 8
12345